Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05643742 |
| Recruiting Status | Recruiting |
| Condition | Non-Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | CRISPR Therapeutics AG |
| Last Updated on CT.gov | November 14, 2025 (Nov 14, 2025) |
As of March 2, 2026: Clinical trial NCT05643742 is currently recruiting participants. This clinical trial study for non-hodgkin lymphoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by CRISPR Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05643742 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05643742 was last updated Nov 14, 2025 (November 14, 2025). HelloStudys verifies this status automatically.